NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.590
+0.100 (6.71%)
At close: Apr 1, 2026, 4:00 PM EDT
1.590
0.00 (0.00%)
After-hours: Apr 1, 2026, 8:00 PM EDT
NovaBay Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
42.33M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 10.46M | -3.95M | -27.42% |
| Dec 31, 2022 | 14.40M | 4.20M | 41.16% |
| Dec 31, 2021 | 10.20M | 270.00K | 2.72% |
| Dec 31, 2020 | 9.93M | 3.34M | 50.54% |
| Dec 31, 2019 | 6.60M | -5.91M | -47.24% |
| Dec 31, 2018 | 12.51M | -5.72M | -31.39% |
| Dec 31, 2017 | 18.23M | 6.33M | 53.23% |
| Dec 31, 2016 | 11.90M | 7.52M | 171.56% |
| Dec 31, 2015 | 4.38M | 3.33M | 315.65% |
| Dec 31, 2014 | 1.05M | -2.42M | -69.69% |
| Dec 31, 2013 | 3.48M | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 9.75M | -5.93M | -37.81% |
| Dec 31, 2009 | 15.68M | 8.96M | 133.32% |
| Dec 31, 2008 | 6.72M | 809.00K | 13.68% |
| Dec 31, 2007 | 5.91M | 4.38M | 285.71% |
| Dec 31, 2006 | 1.53M | - | - |
| Dec 31, 2005 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Atara Biotherapeutics | 120.77M |
| Nutriband | 2.28M |
| RenovoRx | 1.12M |
| Rallybio | 858.00K |
| Lisata Therapeutics | 170.00K |
NBY News
- 8 days ago - NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19% - Benzinga
- 9 days ago - NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - GlobeNewsWire
- 5 months ago - NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 6 months ago - NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting - GlobeNewsWire
- 7 months ago - NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share - GlobeNewsWire
- 8 months ago - NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar - GlobeNewsWire
- 1 year ago - NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire
- 1 year ago - NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire